0775.HK
0775.HK
KYG2176J1058
CKLIFE SCIENCES
Loading chart...

Company Profile

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, trades, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines; supplies raw materials in nutritional health, pharmaceutical, cosmetics, personal care and food segments; financing activities; holding land and buildings; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, the company distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; and produces, refines, and distributes salt products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; develops novel nonopioid therapeutics; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food sectors; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.

Related stocks

1672.HK
1672.HK • Hong Kong SAR China
ASCLETIS-B
6.96 HKD
933.05M USD 1Y -33.7%
115180.KQ
115180.KQ • South Korea
Qurient
22,350 KRW
625.94M USD 1Y +21.9%
476830.KQ
476830.KQ • South Korea
Rznomics
26,300 KRW
550.63M USD
2617.HK
2617.HK • China
TRANSTHERA-B
10.43 HKD
541.23M USD 1Y -92.1%
456160.KQ
456160.KQ • South Korea
G2GBIO
42,000 KRW
518.58M USD 1Y -37.2%
1477.HK
1477.HK • China
OCUMENSION-B
5.08 HKD
517.26M USD 1Y -38.6%
1167.HK
1167.HK • China
JACOBIO-B
5.57 HKD
555.2M USD 1Y -36.4%
085660.KQ
085660.KQ • South Korea
CHA Biotech
8,200 KRW
568.93M USD 1Y -27.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
60.2% p.a.
Max Drawdown (5Y)
-74.6%
Sharpe Ratio (5Y)
-0.15
Beta Factor
0.45
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (60.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -74.6% in the extended horizon.
ende